KZA 0.00% 8.0¢ kazia therapeutics limited

SHARESNovember 18, 2020Why Kazia Therapeutics isAustralia’s...

  1. FWS
    282 Posts.
    lightbulb Created with Sketch. 47


    SHARES

    November 18, 2020

    Why Kazia Therapeutics isAustralia’s biotech shining star

    By Marc Sinatra | More Articles by Marc Sinatra



    Kazia Therapeutics share price has been driven by strong buying in their US-listed ADRs with the company’s market capitalisation moving from $75m to $200m since the Corporate Connect Research report was released. Corporate Connect biotech analyst Marc Sinatra updates the market post the ASX announcement by Kazia of further Paxalisib data.

    For full details refer to the research report below or click here to download your copy.

 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.